Breaking News Instant updates and real-time market news.

ABC

AmerisourceBergen

$89.69

3 (3.46%)

12:45
05/19/17
05/19
12:45
05/19/17
12:45

AmerisourceBergen has a conference call hosted by JPMorgan

JPMorgan Analyst Gill will host a conference call with CEO Steve Collis on May 19 at 1 pm.

  • 19

    May

  • 26

    May

ABC AmerisourceBergen
$89.69

3 (3.46%)

05/17/17
JEFF
05/17/17
INITIATION
Target $95
JEFF
Hold
AmerisourceBergen initiated with a Hold at Jefferies
Jefferies analyst Brian Tanquilut started AmerisourceBergen with a Hold rating and $95 price target. Concerns about generic and branded drug pricing will prevent multiple expansion, the analyst contends.
04/18/17
LEER
04/18/17
NO CHANGE
LEER
Market Perform
Cardinal Health struggles may be benefitting AmerisourceBergen, says Leerink
Leerink analyst David Larsen noted that Cardinal Health (CAH) pointed to generic pricing and sell-side pressure and incremental investments as primary reasons for its FY18 and FY19 adjusted EPS forecasts missing expectations, but he believes there may be other challenges the business is facing too. Cardinal's loss of Prime Therapeutics and Walgreens' (WBA) recent wins from CVS Health (CVS) are other factors that may have hurt Cardinal, said Larsen, who added that both of those will benefit AmerisourceBergen (ABC). The analyst, who also said he is incrementally more cautious on McKesson (MCK) and Owens & Minor (OMI) after Cardinal's call, has an Outperform rating on AmerisourceBergen and Market Perform ratings on Cardinal Health, McKesson and O&M.
04/04/17
NEED
04/04/17
INITIATION
Target $99
NEED
Buy
AmerisourceBergen initiated with a Buy at Needham
Needham analyst Kevin Caliendo started AmerisourceBergen with a Buy rating and $99 price target. The company, with its Walgreens partnership and "solid" free cash flows, is the safest name to own in the distribution space, the analyst contends.
01/17/17
01/17/17
UPGRADE
Target $95

Outperform
AmerisourceBergen upgraded to Outperform at Leerink
As previously reported, Leerink analyst David Larsen upgraded AmerisourceBergen (ABC) to Outperform from Market Perform and raised his price target on the shares to $95 from $75. The analyst believes the odds of the Walgreens Boots Alliance (WBA)/Rite Aid (RAD) transaction going through have "increased substantially," and believes that the long-term partnership with Walgreens Boots Alliance will act as a positive driver for volumes. Long-term, Larsen believes that AmerisourceBergen will continue to benefit from growth in specialty, biosimilars, and generic launches, while recent commentary seems to indicate that generic deflation trends are moderating.

TODAY'S FREE FLY STORIES

BIIB

Biogen

$284.70

1.78 (0.63%)

06:31
07/25/17
07/25
06:31
07/25/17
06:31
Earnings
Biogen reports Q2 adjusted EPS $5.04, consensus $4.41 »

Reports Q2 revenue $3.1B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 01

    Aug

GOOG

Alphabet

$980.34

7.42 (0.76%)

, GOOGL

Alphabet Class A

$998.31

4.47 (0.45%)

06:30
07/25/17
07/25
06:30
07/25/17
06:30
Recommendations
Alphabet, Alphabet Class A analyst commentary  »

Alphabet earnings…

GOOG

Alphabet

$980.34

7.42 (0.76%)

GOOGL

Alphabet Class A

$998.31

4.47 (0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLY

Eli Lilly

$84.74

0.08 (0.09%)

06:30
07/25/17
07/25
06:30
07/25/17
06:30
Hot Stocks
Eli Lilly will pursue new standard-of-care changing therapies in oncology »

Eli Lilly is providing an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 11

    Sep

LLY

Eli Lilly

$84.74

0.08 (0.09%)

06:29
07/25/17
07/25
06:29
07/25/17
06:29
Earnings
Eli Lilly raises FY17 EPS view to $4.10-$4.20 from $4.05-$4.15, consensus $4.12 »

Raises FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 11

    Sep

DDAIF

Daimler AG

$71.00

-1.9399 (-2.66%)

, BMWYY

BMW

$30.72

-0.8 (-2.54%)

06:28
07/25/17
07/25
06:28
07/25/17
06:28
Periodicals
Daimler directors to discuss alleged German auto cartel, Reuters says »

Daimler's (DDAIF)…

DDAIF

Daimler AG

$71.00

-1.9399 (-2.66%)

BMWYY

BMW

$30.72

-0.8 (-2.54%)

VLKAY

Volkswagen

$32.19

-0.79 (-2.40%)

POAHY

Porsche

$5.82

-0.03 (-0.51%)

AUDVF

Audi AG

$835.60

-4.8 (-0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WERN

Werner

$29.20

-0.35 (-1.18%)

06:28
07/25/17
07/25
06:28
07/25/17
06:28
Upgrade
Werner rating change  »

Werner upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

TNTR

Tintri

$6.95

0.16 (2.36%)

06:28
07/25/17
07/25
06:28
07/25/17
06:28
Initiation
Tintri initiated  »

Tintri initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BY

Byline Bancorp

$20.85

0.13 (0.63%)

06:28
07/25/17
07/25
06:28
07/25/17
06:28
Initiation
Byline Bancorp initiated  »

Byline Bancorp initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jul

LLY

Eli Lilly

$84.74

0.08 (0.09%)

06:26
07/25/17
07/25
06:26
07/25/17
06:26
Earnings
Eli Lilly reports Q2 EPS $1.11, consensus $1.05 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 11

    Sep

NCMGY

Newcrest Mining

$15.72

0.12 (0.77%)

06:26
07/25/17
07/25
06:26
07/25/17
06:26
Upgrade
Newcrest Mining rating change  »

Newcrest Mining upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPNC

Spectranetics

$38.50

0.05 (0.13%)

06:21
07/25/17
07/25
06:21
07/25/17
06:21
Downgrade
Spectranetics rating change  »

Spectranetics downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMP

Tompkins Financial

$78.41

-0.14 (-0.18%)

06:21
07/25/17
07/25
06:21
07/25/17
06:21
Upgrade
Tompkins Financial rating change  »

Tompkins Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNE

Sony

$40.61

-0.2 (-0.49%)

, AAPL

Apple

$152.09

1.82 (1.21%)

06:20
07/25/17
07/25
06:20
07/25/17
06:20
Periodicals
Sony restructures television production unit, WSJ reports »

Sony Pictures…

SNE

Sony

$40.61

-0.2 (-0.49%)

AAPL

Apple

$152.09

1.82 (1.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

LLY

Eli Lilly

$84.74

0.08 (0.09%)

, INCY

Incyte

$138.27

4.05 (3.02%)

06:20
07/25/17
07/25
06:20
07/25/17
06:20
Hot Stocks
Eli Lilly, Incyte resubmit baricitinib NDA to FDA »

Eli Lilly (LLY) and…

LLY

Eli Lilly

$84.74

0.08 (0.09%)

INCY

Incyte

$138.27

4.05 (3.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 01

    Aug

  • 11

    Sep

SSB

South State

$83.90

0.7 (0.84%)

06:19
07/25/17
07/25
06:19
07/25/17
06:19
Upgrade
South State rating change  »

South State upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 18

    Sep

BSRR

Sierra Bancorp

$24.15

0.34 (1.43%)

06:19
07/25/17
07/25
06:19
07/25/17
06:19
Upgrade
Sierra Bancorp rating change  »

Sierra Bancorp upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

BY

Byline Bancorp

$20.85

0.13 (0.63%)

06:17
07/25/17
07/25
06:17
07/25/17
06:17
Initiation
Byline Bancorp initiated  »

Byline Bancorp initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jul

GOOGL

Alphabet Class A

$998.31

4.47 (0.45%)

, GOOG

Alphabet

$980.34

7.42 (0.76%)

06:16
07/25/17
07/25
06:16
07/25/17
06:16
Recommendations
Alphabet Class A, Alphabet analyst commentary  »

Alphabet post-earnings…

GOOGL

Alphabet Class A

$998.31

4.47 (0.45%)

GOOG

Alphabet

$980.34

7.42 (0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LULU

lululemon

$62.02

0.08 (0.13%)

06:16
07/25/17
07/25
06:16
07/25/17
06:16
Downgrade
lululemon rating change  »

lululemon downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

WBMD

WebMD

$66.10

10.91 (19.77%)

06:14
07/25/17
07/25
06:14
07/25/17
06:14
Downgrade
WebMD rating change  »

WebMD downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WBMD

WebMD

$66.10

10.91 (19.77%)

06:13
07/25/17
07/25
06:13
07/25/17
06:13
Downgrade
WebMD rating change  »

WebMD downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BKS

Barnes & Noble

$7.10

-0.05 (-0.70%)

06:12
07/25/17
07/25
06:12
07/25/17
06:12
Periodicals
Activist investor Sandell urges Barnes & Noble to sell, WSJ reports »

Sandell Asset Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKZOY

AkzoNobel

$29.20

-0.45 (-1.52%)

06:12
07/25/17
07/25
06:12
07/25/17
06:12
Hot Stocks
Breaking Hot Stocks news story on AkzoNobel »

AkzoNobel says to hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKZOY

AkzoNobel

$29.20

-0.45 (-1.52%)

06:11
07/25/17
07/25
06:11
07/25/17
06:11
Hot Stocks
Breaking Hot Stocks news story on AkzoNobel »

AkzoNobel creating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKZOY

AkzoNobel

$29.20

-0.45 (-1.52%)

06:11
07/25/17
07/25
06:11
07/25/17
06:11
Hot Stocks
Breaking Hot Stocks news story on AkzoNobel »

AkzoNobel supervisory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.